About CoreMap
CoreMap is a Healthcare company based in Burlington (United States) founded in 2017. It operates as an atrial fibrillation detection platform is provided for heart disorder management. CoreMap has raised $66.81 million across 7 funding rounds from investors including Russ Scully, Qure Ventures and Ronny Ginor. Its chief executive is Sarah O'Connell Kalil. CoreMap offers products and services including AF Visualization Device and Spatial Resolution Technology. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, In-Vitro Diagnostics and Arrhythmia. Its legal entity is CoreMap Inc. Its competitors include Wearlinq, Topera, Cardinor, Bionet and Koshihikari and 4 more; 4 of its 9 listed competitors have raised funding.
Company details
CoreMap was founded in 2017 and is based in Burlington, United States. A platform is offered in the medical technology sector to detect atrial fibrillation and manage heart disorders. Cardiac electrophysiology mapping software is developed by the company, integrating with diagnostic catheters for patient assessment. AF vitals are generated to inform clinical decisions and improve health outcomes in cardiac care.
- Headquarters Burlington, United States
- SectorsHealthcare
- Website coremapmedical.com
- Social LinkedIn
- Legal Name Coremap Inc
- Total Equity Funding$66.81M (USD)
in 7 rounds
- Latest Funding Round$35.51M (USD), Series C
Jun 2026
- InvestorsQure Ventures
& 4 more
Products & Services of CoreMap
CoreMap offers a comprehensive portfolio of products and services, including AF Visualization Device and Spatial Resolution Technology.
Tool for mapping atrial fibrillation to assist in heart treatment decisions
Enhances accuracy in atrial fibrillation detection and analysis
Funding Insights of CoreMap
CoreMap has successfully raised a total of $66.81M across 7 strategic funding rounds. The most recent funding activity was a Series C round of $35.51 million completed in June 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $66.81M
- Total Rounds 7
- Last Round Series C — $35.51M
- First Round $300,000
(Sep 2017)
- Investors Count 5
All 7 funding rounds of CoreMap with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2026 | $35.51M | Series C | – | – | – |
| Feb 2022 | $20M | Series B | – | Qure Ventures | |
| Sep 2020 | $10.5M | Series A | – | Qure Ventures | |
| Sep 2020 | $251,134 | Grant | – | – | |
| Sep 2020 | $251,134 | Grant | – | – | |
| Apr 2019 | $500,000 | Seed | – | – | – |
| Sep 2017 | $300,000 | Seed | – | – | – |
5 investors in total: 3 institutional and 2 angel.
Investors in CoreMap
CoreMap has secured backing from 5 investors, including angel, venture fund, and institutional investors. Prominent investors backing the company include Russ Scully, Qure Ventures and Ronny Ginor.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Seed & early stage Digital Health focused VC firm funding companies in Israel | – | qureventures.com | Herzliya, Israel | |
Venture capital fund backed by the US Government | – | seedfund.nsf.gov | Alexandria, United States | |
A government-backed foundation providing seed-stage investments to support small businesses. | 1950 | nsf.gov | Arlington, United States | |
RS Russ Scully | Angel investor, entrepreneur, known for early tech investments and bold personality. | – | unknown_02e4ba1c5e2247a9a | - |
RG Ronny Ginor | - | – | unknown_207d542be2654b89a | - |
Investor details for CoreMap
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of CoreMap
19 people are tracked at CoreMap (9 in leadership, 10 in team).
| Name | Role | Group |
|---|---|---|
Sarah O'Connell Kalil | CEO | Leadership |
Sarah Kalil | Co-Founder, President, and CEO | Leadership |
Amanda Fleury | Director Of Business And Operations Administration | Leadership |
Steven Berlin | Head Of Operations | Leadership |
Doron Feinstein | VP Of R&d | Leadership |
William Quinn | Head of Catheter Engineering - Medical Device | Leadership |
yao li | Head Of Software Engineering | Leadership |
Matthew Crema | Head Of Data Science | Leadership |
Al Dunfee | Head Of Engineering | Leadership |
Leah Trocchi | Senior Associate, Business Administration | Team |
Gayle Tropeano | Engineering Service Lead | Team |
Shubhro Saha | Catheter Mechanical Engineer | Team |
Xi Zhao | Software Engineer | Team |
David Smith | Technical Program Manager | Team |
Piotr Rotkiewicz | Senior Software Engineer | Team |
Emanuel Demaio | Senior System Engineering Lead | Team |
John Yun Qiao | Signal Processing Engineer | Team |
Anna W. | Data Scientist | Team |
Christopher Ayers | Data Scientist | Team |
Complete people profiles for CoreMap
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of CoreMap
3 dated milestones of CoreMap across 9 years, from founding to its latest funding, stage changes and deals.
- Founded CoreMap is founded.
- Funding First funding round of $300K.
- Funding Latest funding round, Series C, of $35.5M.
Competitors of CoreMap
CoreMap has 9 listed competitors in our database, 4 of them funded. They include Wearlinq, Topera, Cardinor, Bionet and Koshihikari, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| wearlinq.com | 2019 | Stanford, United States | $12.28M | – | A wearable ECG device is provided for heart disorder detection. | |
| toperamedical.com | 2010 | Menlo Park, United States | $31.52M | – | Catheter-based electrophysiology mapping for atrial fibrillation treatment is offered. | |
| cardinor.com | 2015 | Oslo, Norway | $921,842 | 2 | Biomarker-based assays for cardiovascular diseases are developed and provided. | |
| babybanks.com | 1999 | Taipei, Taiwan | – | – | Cord blood banking service provider along with services on genetic testing | |
| prudencemed.com | 2013 | China | – | – | AI-based ECG diagnostic systems for cardiovascular disease detection are provided. | |
| rapid-rhythm.com | 2011 | Manchester, United Kingdom | $80,305 | 1 | Offers a device for early detection of atrial fibrillation in healthcare settings. | |
| getsmartheart.com | 2011 | Easthampton, United States | – | – | Portable EKG device for home-based cardiac monitoring and early detection of issues. | |
| wegene.com.tw | 2000 | Taipei, Taiwan | – | – | Wireless ECG & autonomic nerve analyzer for cardiac diagnostics | |
| deltavital.eu | 2014 | Gothenburg, Sweden | – | – | Develops novel risk markers for detecting arrhythmia in patients. |
Detailed competitors of CoreMap
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of CoreMap
The website of CoreMap (coremapmedical.com) receives about 2.9K visits a month.
- Monthly visits2.9K
▲ 22.8% vs previous month
Top companies in Cardiac and Vascular Disorders
10 companies that operate in the same segment as CoreMap (Cardiac and Vascular Disorders), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
SMT is recognized as a developer of cardiovascular medical devices. | 1998 | Surat, Gujarat, India | – | USD 106.25 M | 1,090 | |
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | – | 255 | |
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 | |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided. | 2006 | San Francisco, California, United States | USD 109.23 M | USD 747.14 M | 2,000 | |
Provider of neuroprotection devices for carotid artery disease | 2007 | Sunnyvale, California, United States | USD 241.8 M | – | – | |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. | 2007 | East Peoria, Illinois, United States | USD 154.77 M | – | 104 | |
Access catheters for neurovascular stroke treatment are provided. | 2015 | Campbell, California, United States | USD 596 M | – | – | |
Biosensor patches are developed for monitoring multiple body vitals. | 2011 | Campbell, California, United States | USD 239.95 M | – | 184 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Coremap
Complete news archive for CoreMap
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CoreMap
CoreMap was founded in 2017.
CoreMap is headquartered in Burlington, United States. It is registered at Burlington, Vermont, United States.
Sarah O'Connell Kalil is the current CEO of CoreMap.
CoreMap is a funded company, having raised a total of $66.81M across 7 funding rounds to date. The company's 1st funding round was a Seed of $300K, raised on Sep 2017.
CoreMap was founded in 2017 and is based in Burlington, United States. A platform is offered in the medical technology sector to detect atrial fibrillation and manage heart disorders. Cardiac electrophysiology mapping software is developed by the company, integrating with diagnostic catheters for patient assessment. AF vitals are generated to inform clinical decisions and improve health outcomes in cardiac care.
CoreMap offers AF Visualization Device and Spatial Resolution Technology.
CoreMap has 5 investors. Key investors include Russ Scully, Qure Ventures, Ronny Ginor, America’s Seed Fund, and National Science Foundation.
CoreMap operates through Coremap Inc.